International Liver Congress

Meeting NewsVideo

Zepatier for 8 weeks safe, effective for HCV genotypes 1b, 4

April 20, 2018
PARIS — In this exclusive interview from the International Liver Congress 2018, Christophe Hezode, MD, discusses positive study results from…
Meeting NewsVideo

Obeticholic acid improved, stabilized fibrosis after incomplete response to UDCA

April 18, 2018
PARIS — Most patients with primary biliary cholangitis who had an incomplete response to ursodeoxycholic acid achieved stabilization or…
Meeting News

Intragastric balloon for fatty liver intervention does not affect gut microflora

April 18, 2018
PARIS — Patients with obesity and nonalcoholic fatty liver disease who underwent assisted weightloss with an intragastric balloon showed no…
Meeting NewsVideo

Givosiran reduces neurotoxic intermediates in acute hepatic porphyrias

April 17, 2018
PARIS — Givosiran, an investigational RNA interference therapeutic, was generally well-tolerated and reduced aminolevulinic acid and…
Meeting NewsVideo

Fecal microbiota transplant improves brain function in hepatic encephalopathy

April 17, 2018
PARIS — Patients who underwent fecal microbiota transplant for recurrent hepatic encephalopathy had a lower risk for hospitalization and showed…
Meeting News

Growth factor improved fatty liver score in 84% of patients

April 16, 2018
PARIS — Patients who received NGM282, a novel growth factor, showed improved noninvasive markers of nonalcoholic steatohepatitis and a…
Meeting News

Patients with chronic HCV at higher risk for ICD-10-classified diseases

April 16, 2018
Patients with chronic hepatitis C virus infection are at a higher risk of being diagnosed with around 70% of the diseases captured by the ICD-10…
Meeting News

DAA therapy effective in patients with HCV and advanced cirrhosis

April 16, 2018
PARIS — Direct-acting antiviral therapy effectively treated hepatitis C virus in patients with high MELD scores, producing a high rate of…
Meeting News

Lymphoma incidence 15 times higher in HIV/HCV coinfection

April 15, 2018
The incidence of lymphoma — Hodgkin and non-Hodgkin — was up to 15 times higher among patents with HIV monoinfection and HIV/hepatitis C…
Meeting News

Galectin-3 inhibitor improves hepatic ballooning in NASH

April 14, 2018
PARIS — GR-MD-02, a novel galectin-3 protein, did not improve hepatic venous pressure gradient in patients with nonalcoholic steatohepatitis…